Interpreting the RAPIDO trial: factors to consider - Authors' reply

Affiliations

¹ Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.
² Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.
³ Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.
⁴ Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
⁵ Department of Biomedical Datasciences, Leiden University Medical Center, Leiden, Netherlands.
⁶ Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.
⁷ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
⁸ Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands. Electronic address: g.a.p.hospers@umcg.nl.

PMID: 33662297
DOI: 10.1016/S1470-2045(21)00087-5

Comment

Interpreting the RAPIDO trial: factors to consider - Authors' reply

Renu R Bahadoer et al. Lancet Oncol. 2021 Mar.

. 2021 Mar;22(3):e90-e91.

doi: 10.1016/S1470-2045(21)00087-5.

Affiliations

¹ Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.
² Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.
³ Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.
⁴ Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
⁵ Department of Biomedical Datasciences, Leiden University Medical Center, Leiden, Netherlands.
⁶ Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.
⁷ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
⁸ Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands. Electronic address: g.a.p.hospers@umcg.nl.

PMID: 33662297
DOI: 10.1016/S1470-2045(21)00087-5

No abstract available

PubMed Disclaimer

Comment on

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP; RAPIDO collaborative investigators. Bahadoer RR, et al. Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7. Lancet Oncol. 2021. PMID: 33301740 Clinical Trial.
Interpreting the RAPIDO trial: factors to consider.
Glynne-Jones R. Glynne-Jones R. Lancet Oncol. 2021 Mar;22(3):e85. doi: 10.1016/S1470-2045(21)00013-9. Lancet Oncol. 2021. PMID: 33662293 No abstract available.
Interpreting the RAPIDO trial: factors to consider.
Kumar NAN. Kumar NAN. Lancet Oncol. 2021 Mar;22(3):e86. doi: 10.1016/S1470-2045(21)00011-5. Lancet Oncol. 2021. PMID: 33662294 No abstract available.
Interpreting the RAPIDO trial: factors to consider.
Yuval JB, Patil S, Garcia-Aguilar J. Yuval JB, et al. Lancet Oncol. 2021 Mar;22(3):e87-e88. doi: 10.1016/S1470-2045(21)00061-9. Lancet Oncol. 2021. PMID: 33662295 No abstract available.
Interpreting the RAPIDO trial: factors to consider.
Pastorino A, Negru ME, Aschele C. Pastorino A, et al. Lancet Oncol. 2021 Mar;22(3):e89. doi: 10.1016/S1470-2045(21)00072-3. Lancet Oncol. 2021. PMID: 33662296 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Interpreting the RAPIDO trial: factors to consider - Authors' reply

Affiliations

Interpreting the RAPIDO trial: factors to consider - Authors' reply

Authors

Affiliations

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources